Altesa BioSciences is a startup based in the United States, most recent round Series B, 1 tracked investor.
Altesa BioSciences is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Altesa BioSciences is a clinical-stage pharmaceutical company focused on developing antiviral medicines to treat respiratory infections, particularly targeting rhinovirus as the main cause of exacerbations in chronic lung diseases like COPD and asthma.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.